Glumetinib Unknown Status Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03466268Study to Evaluate the Safety and Anti-tumor Activity of SCC244
NCT03457532A Phase I Study of SCC244